Viatris Innovation Gmbh

This trial investigates whether a single injection of selatogrel can quickly prevent platelets from clumping together in people with stable coronary artery disease. Researchers are also checking how fast the drug works, how long it lasts, and whether injecting it in the thigh or …

This study tested a new drug called cenerimod in 105 people with systemic lupus erythematosus (SLE), an autoimmune disease. The goal was to see if the drug could safely lower certain immune cells (lymphocytes) in the blood, which may help control the disease. Participants continu…

This study tested four doses of cenerimod, a daily pill that calms the immune system, against a placebo in 427 adults with moderate-to-severe lupus. The main goal was to see if cenerimod could reduce lupus disease activity over six months. Researchers also checked for safety and …

This phase 2 trial tests whether a single injection of selatogrel can rapidly prevent platelets from clumping together in adults having a heart attack. Participants receive either an 8 mg or 16 mg dose in the thigh, and researchers measure how quickly platelet activity drops. The…

This study measured how much of the drug cenerimod gets into the blood after swallowing a tablet. Six healthy men took one pill, then received a tiny radioactive version of the drug through a vein. They stayed at the clinic for 4 days and returned for checkups over 3 months. The …

This completed Phase 1 trial studied how a single 16 mg dose of selatogrel is absorbed and processed in the body of 32 healthy volunteers (16 Japanese and 16 Caucasian). The study did not aim to treat any condition, but to gather safety and drug-level data. Participants stayed in…

This study gave a single dose of a radiolabeled drug called cenerimod to 6 healthy men aged 45-65. The goal was to see how quickly and by what routes (urine, feces, breath) the drug leaves the body. It is a Phase 1 trial with no treatment benefit, purely to gather information for…

This early-stage study tested a single 4 mg dose of the drug cenerimod in 20 healthy volunteers (10 Japanese and 10 Caucasian). The goal was not to treat any disease but to see how safe the drug is and how the body absorbs and breaks it down. Participants stayed in the clinic for…

This completed Phase 1 study looked at how a single 0.5 mg dose of the drug cenerimod is processed in 24 people — some with mild or moderate liver impairment and some healthy. The goal was to see if liver problems change drug levels or safety. Participants were monitored for side…

This study looked at how the drug cenerimod is processed in people with severe kidney impairment compared to healthy people. A total of 16 participants took a single 0.5 mg dose of cenerimod. Researchers measured drug levels in the blood and checked safety markers like heart rhyt…

This early-stage trial in 97 healthy adults checks if cenerimod, an experimental drug, affects heart rhythm (QT interval) and how it interacts with birth control pills and activated charcoal. Participants receive either placebo, low or high dose cenerimod, or a control drug (moxi…